SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-073686
Filing Date
2018-12-19
Accepted
2018-12-19 08:00:25
Documents
5
Period of Report
2018-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41788_18k.htm 8-K 37535
2 EX-2.1 a18-41788_1ex2d1.htm EX-2.1 472007
3 EX-10.1 a18-41788_1ex10d1.htm EX-10.1 394446
4 EX-99.1 a18-41788_1ex99d1.htm EX-99.1 11830
5 GRAPHIC g417881mmi001.jpg GRAPHIC 5460
  Complete submission text file 0001104659-18-073686.txt   924936
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 181242229
SIC: 3845 Electromedical & Electrotherapeutic Apparatus